Objective To analyzed the genetic diversity, genetic differences between populations and differentiation time of Echinococcus granulosus and E. multilocularis of Qinghai isolates, in order to provide scientific basis for species tracing and prevention and control of Echinococcus in Qinghai Province, China. Methods For genetic analysis, 50 liver lesion samples were collected from hospitalized echinococcosis patients in the Affiliated Hospital of Qinghai University to extract genomic DNA and amplify mitochondrial dehydrogenase 1 gene (nad1). Sequence multiple alignment was performed using Clustal X v2.0 software. Geographic informatics mapping of patients’ residence was constructed using ArcGIS software. Sequence haplotype analysis was made with DnaSP v6 software. Modeltest 3.7 software and PAUP*4.0B10 software were used to calculate the minimum optimal nucleic acid evolution model. The Bayesian’s phylogenetic evolution tree was constructed with MrBayes-3.2.7 software. The differentiation time of each node in the phylogenetic tree was estimated with the Bayesian method using BEAST v2.6.3 software. Results We successfully identified 48 Echinococcus lesion samples specimen and obtained the full length of complete nad1 gene of 894 bp. Among them, 13 samples were identified as the G1 genotype of E. granulosus, and 35 samples as E. multilocularis. All the sequences showed > 99% similarity to those in GenBank. Four haplotypes were identified as H1-H4 in the two species respectively; H3 was the dominant haplotype in E. granulosus samples(10/13), which is present in Xining, Guoluo, Yushu, Haidong, Haibei and Huangnan. H2 haplotype was found dominant in E. multilocular samples (51.4%,18/35), which is present in Xining, Guoluo, Yushu, and Haidong. The phylogenetic tree showed that E. granulosus and G1 genotype clustered into one branch, and E. multilocularis and Asian strain clustered into one branch. The results of differentiation time showed that the nearest common ancestor of E. granulosus, E. multilocularis, E. vogeli and E. oligarthrus was about 5.5 Mya (95% confidence interval 4.5-6.5 Mya), and the differentiation time of E. granulosus and E. multilocularis was about 2.5 Mya (95% confidence interval 2.3-4.1 Mya). Conclusion Both human E. granulosus and E. multilocularis in Qinghai Province show high genetic diversity. E. granulosus was found of G1 genotype, with H3 as the dominant haplotype, while in E. multilocularis samles H2 is the dominant. The two speies are widely distributed throughout Qinghai Province. The two species of Echinococcus exhit closer genetic relationship and differentiation timing.
CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats)/(CRISPR-associated protein 9) is an efficient genome editing system for targeted gene disruption, site-specific insertion of foreign DNA, gene repair, etc., which provides an innovation platform of technology for functional analysis of parasite genes and selection of drug targets and vaccine candidates. Here, we review the mechanism of CRISPR/Cas9 and some recent findings on the use of CRISPR/Cas9 in parasite research, particularly in studies of Toxoplasma gondii, Plasmodium, Trypanosoma and Leishmania. The challenges and optimization strategies of the CRISPR/Cas9 system at the present stage are also discussed.
The Chinese Journal of Parasitology and Parasitic Diseases had its first issue in 1983. Over the past 40 years, the journal witnesses the remarkable achievements in prevention and control of important parasitic diseases in China, marked by effective control of schistosomiasis (2015) and elimination of lymphatic filariasis (2007) and malaria (2021), and has been playing an important role providing academic exchange platform for research and control programs of parasitic diseases and parasitology, promoting domestic and international scientific exchanges. With the guidance of each editorial board, the journal strictly abides by the academic standards and perseveres the concept of presenting high-quality publication. The national and international impact of the journal has continuously increased. It has been included in important international databases such as Medline, Scopus, and Chinese Science Citation Database (CSCD) (Class C) since 1989. It has been selected as one of Chinese Science and Technology Core Journals since 1987, Core Journals in Chinese since 1992 and the World Journal Clout Index Report Scientific & Technological Periodicals (WJCI) since 2020, and was included in the High-Quality Scientific and Technological Journal Classification Catalog for Preventive Medicine and Health (2021 edition). It was also awarded as one of “the 100 Outstanding Chinese Academic Journals” (in 2009), “the First Prize of Excellent Medical and Health Journals of the Ministry of Health” (in 2005), “the First Prize of Excellent Journals of the National Health and Family Planning Commission” (in 2013), the First Prize and the Excellent Journal of “the Journal series of the Chinese Preventive Medicine Association” and “the Excellent Journal Award in East China Region”. In 2021, its core impact factor reached 1.743, the highest in its history, and continues its first rank among 31 core journals in medicine. The network informatization has been constructed since 2006, with "WeChat" platform established in 2016, which has raised the journal’s dissemination, service capacity and impact to a higher level. This article summarizes the 40-year history of the Chinese Journal of Parasitology and Parasitic Diseases, and prospects its future development direction.
After more than 70 years of effective control programme, China has made remarkable achievements in the control of key parasitic diseases, and is moving towards the goal of control and elimination. This paper analyzes the epidemic status and challenges of schistosomiasis, malaria, echinococcosis, leishmaniasis, clonorchiasis and soil-transmitted helminthiasis in recent years, and puts forward the future directions and key tasks of those diseases, in order to provide reference for accelerating the control and elimination programmes on key parasitic diseases in China.